Status:

UNKNOWN

Prediction of the Development of Heart Failure With Preserved Ejection Fraction

Lead Sponsor:

Heart Center Leipzig - University Hospital

Conditions:

Heart Failure With Preserved Ejection Fraction

Eligibility:

All Genders

18+ years

Brief Summary

The ultimate goal of the PREDICT-HFpEF study is to identify and unravel predictors for the development of heart failure with preserved ejection fraction (HFpEF) in a cohort at increased cardiovascular...

Detailed Description

Heart failure with preserved ejection fraction (HFpEF) is associated with severe morbidtiy and mortality. Yet, little is known about factors leading to the development of HFpEF investigated in a longi...

Eligibility Criteria

Inclusion

  • At timepoint of inclusion in the LIFE-Heart study normal left ventricular ejection fraction (≥ 50%)
  • At timepoint of inclusion in the LIFE-Heart study normal NT-proBNP (\< 125 ng/l)

Exclusion

  • At timepoint of inclusion in the LIFE-Heart study acute coronary syndrom
  • Troponine elevation above 14 pg/ml as well as coronary intervention, or isolated troponine elevation above 50 pg/ml in the absence of a coronary intervention
  • No troponine elevation but coronary intervention
  • Creatine kinase \> 0.41 µmol/l\*s and Creatine kinase to Creatine kinase-MB ration \>6% or Creatine kinase-MB \> 0.82 µmol/l\*s
  • At timepoint of inclusion in the LIFE-Heart study missing data on left ventricular ejection fraction
  • At timepoint of inclusion in the LIFE-Heart study missing NT-proBNP measurement
  • At timepoint of inclusion in the LIFE-Heart study missing data on echocardiographic diastolic function and structural alterations of the left ventricle
  • At timepoint of inclusion in the LIFE-Heart study relevant valvular heart disease (including relevant aortic stenosis, mitral- and/or tricuspid regurgitation, congenital heart disease, mitral stenosis)

Key Trial Info

Start Date :

December 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2022

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT04894968

Start Date

December 1 2018

End Date

November 1 2022

Last Update

March 17 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Heart Center Leipzig at Leipzig University

Leipzig, Saxony, Germany, 04289